| Product Code: ETC11272398 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India In-Vitro Diagnostics for Cardiology and Neurology Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India In-Vitro Diagnostics for Cardiology and Neurology Market Revenues & Volume, 2021 & 2031F |
3.3 India In-Vitro Diagnostics for Cardiology and Neurology Market - Industry Life Cycle |
3.4 India In-Vitro Diagnostics for Cardiology and Neurology Market - Porter's Five Forces |
3.5 India In-Vitro Diagnostics for Cardiology and Neurology Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 India In-Vitro Diagnostics for Cardiology and Neurology Market Revenues & Volume Share, By Biomarker Type, 2021 & 2031F |
3.7 India In-Vitro Diagnostics for Cardiology and Neurology Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 India In-Vitro Diagnostics for Cardiology and Neurology Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 India In-Vitro Diagnostics for Cardiology and Neurology Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cardiovascular and neurological disorders in India |
4.2.2 Technological advancements in in-vitro diagnostics for cardiology and neurology |
4.2.3 Growing demand for personalized medicine and targeted therapies in the healthcare sector |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of in-vitro diagnostics products |
4.3.2 Limited awareness and adoption of advanced diagnostic technologies in certain regions of India |
4.3.3 High cost associated with in-vitro diagnostics tests for cardiology and neurology |
5 India In-Vitro Diagnostics for Cardiology and Neurology Market Trends |
6 India In-Vitro Diagnostics for Cardiology and Neurology Market, By Types |
6.1 India In-Vitro Diagnostics for Cardiology and Neurology Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 India In-Vitro Diagnostics for Cardiology and Neurology Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 India In-Vitro Diagnostics for Cardiology and Neurology Market Revenues & Volume, By Cardiac Biomarkers, 2021 - 2031F |
6.1.4 India In-Vitro Diagnostics for Cardiology and Neurology Market Revenues & Volume, By Neurological Biomarkers, 2021 - 2031F |
6.1.5 India In-Vitro Diagnostics for Cardiology and Neurology Market Revenues & Volume, By Genetic Markers, 2021 - 2031F |
6.1.6 India In-Vitro Diagnostics for Cardiology and Neurology Market Revenues & Volume, By Others, 2021 - 2031F |
6.2 India In-Vitro Diagnostics for Cardiology and Neurology Market, By Biomarker Type |
6.2.1 Overview and Analysis |
6.2.2 India In-Vitro Diagnostics for Cardiology and Neurology Market Revenues & Volume, By Troponin, 2021 - 2031F |
6.2.3 India In-Vitro Diagnostics for Cardiology and Neurology Market Revenues & Volume, By Amyloid Beta, 2021 - 2031F |
6.2.4 India In-Vitro Diagnostics for Cardiology and Neurology Market Revenues & Volume, By APOE Testing, 2021 - 2031F |
6.3 India In-Vitro Diagnostics for Cardiology and Neurology Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 India In-Vitro Diagnostics for Cardiology and Neurology Market Revenues & Volume, By Heart Attack Detection, 2021 - 2031F |
6.3.3 India In-Vitro Diagnostics for Cardiology and Neurology Market Revenues & Volume, By Alzheimer's Diagnosis, 2021 - 2031F |
6.3.4 India In-Vitro Diagnostics for Cardiology and Neurology Market Revenues & Volume, By Stroke Risk Assessment, 2021 - 2031F |
6.3.5 India In-Vitro Diagnostics for Cardiology and Neurology Market Revenues & Volume, By Neurodegenerative Disorders, 2021 - 2031F |
6.4 India In-Vitro Diagnostics for Cardiology and Neurology Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 India In-Vitro Diagnostics for Cardiology and Neurology Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.4.3 India In-Vitro Diagnostics for Cardiology and Neurology Market Revenues & Volume, By Diagnostic Labs, 2021 - 2031F |
6.4.4 India In-Vitro Diagnostics for Cardiology and Neurology Market Revenues & Volume, By Research Centers, 2021 - 2031F |
6.4.5 India In-Vitro Diagnostics for Cardiology and Neurology Market Revenues & Volume, By Clinics, 2021 - 2031F |
7 India In-Vitro Diagnostics for Cardiology and Neurology Market Import-Export Trade Statistics |
7.1 India In-Vitro Diagnostics for Cardiology and Neurology Market Export to Major Countries |
7.2 India In-Vitro Diagnostics for Cardiology and Neurology Market Imports from Major Countries |
8 India In-Vitro Diagnostics for Cardiology and Neurology Market Key Performance Indicators |
8.1 Adoption rate of advanced in-vitro diagnostics technologies in cardiology and neurology |
8.2 Number of partnerships and collaborations for research and development in the field |
8.3 Rate of integration of in-vitro diagnostics with healthcare information systems |
8.4 Patient outcomes and improvement in treatment efficacy |
8.5 Level of government support and funding for in-vitro diagnostics research and innovation |
9 India In-Vitro Diagnostics for Cardiology and Neurology Market - Opportunity Assessment |
9.1 India In-Vitro Diagnostics for Cardiology and Neurology Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 India In-Vitro Diagnostics for Cardiology and Neurology Market Opportunity Assessment, By Biomarker Type, 2021 & 2031F |
9.3 India In-Vitro Diagnostics for Cardiology and Neurology Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 India In-Vitro Diagnostics for Cardiology and Neurology Market Opportunity Assessment, By End User, 2021 & 2031F |
10 India In-Vitro Diagnostics for Cardiology and Neurology Market - Competitive Landscape |
10.1 India In-Vitro Diagnostics for Cardiology and Neurology Market Revenue Share, By Companies, 2024 |
10.2 India In-Vitro Diagnostics for Cardiology and Neurology Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here